The George Institute and UNSW Founders Build Ecosystem for Health Innovations

The George Institute and UNSW Founders Build Ecosystem for Health Innovations

In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]

了解更多

2019年9月11日
[addtoany buttons='facebook,twitter,linkedin']

Professor Bruce Neal Appointed Executive Director of The George Institute

乔治临床( George Clinical ) is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1.   Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton.  Neal has contributed to the growth of the Institute across […]

了解更多

2019年9月5日
[addtoany buttons='facebook,twitter,linkedin']

WHO Endorsement of Simpler Drug Treatment for Blood Pressure Will Improve Treatment Availability for 1 Billion People

乔治临床( George Clinical ) welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, The George Institute and other partners. Adding FDCs of blood […]

了解更多

2019年7月31日
[addtoany buttons='facebook,twitter,linkedin']

The George Institute Researchers Find Diabetes Increases the Risk of Heart Failure for Women at a Higher Rate

A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men.  Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]

了解更多

2019年7月19日
[addtoany buttons='facebook,twitter,linkedin']

Big and Small Pharma Enjoy a Significant Opportunity to Leverage India for Trials

The Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already a leading destination for global clinical trials with significant growth taking place in the biotech sector.   Prime opportunities exist for all phases of clinical trials due to […]

了解更多

2019年7月17日
[addtoany buttons='facebook,twitter,linkedin']

Award Highlights 乔治临床( George Clinical ) as Leading Employer in Asia-Pacific Region

Last year 乔治临床( George Clinical ) gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Schemes Authority (MPFA) awarded 乔治临床( George Clinical ) their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, […]

了解更多

2019年7月13日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Announces the Appointment of Meelian Hoh as Chief Financial Officer

SYDNEY, June 17, 2019 – 乔治临床( George Clinical ), a global scientifically driven CRO, today announced the appointment of Meelian Hoh to the role of Chief Financial Officer. With extensive financial management experience spanning more than 20 years, Hoh brings leadership in financial accountability, enterprise system implementation and pharma industry market knowledge to the 乔治临床( […]

了解更多

2019年6月18日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Welcomes FDA Framework for Real World Evidence Program

December of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved under section 505(c) of the FD&C Act.  This document was developed to outline guidance and support of real world data collection efforts for post-approval […]

了解更多

2019年6月1日
[addtoany buttons='facebook,twitter,linkedin']

CTTI Recommendations Developed to Improve Engagement in Mobile Clinical Trials

乔治临床( George Clinical ) is proud to have been involved in developing the recently announced recommendations by the Clinical Trial Transformation Initiative (CTTI): The Recommendations for Engaging Patients and Sites in Mobile Clinical Trials. The recommendations, to which 乔治临床( George Clinical ) contributed as a member on the expert committee, aim to help research organizations, […]

了解更多

2019年6月1日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 – 乔治临床( George Clinical ), a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines.  The office is based in the capital city, Manila and compliments the organization’s growing list of global locations.   The opening of […]

了解更多

2019年5月29日
[addtoany buttons='facebook,twitter,linkedin']

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )